A Gordon Smith

4PUBLICATIONS
13CO-AUTHORS
Gene and molecular therapyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Jan 16, 2026
Biosimilar Therapeutics Substitution: American Academy of Neurology Position Statement.

Jonathan D Santoro, Jonathan Crowe, Cale H Coppage

|Apr 20, 2024
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison.

Cécile van Steen, Lorenzo Celico, Erik Spaepen

Pageof 1

Frequent Collaborators

1 joint publications

Cécile van Steen

1 joint publications

Tim Hagenacker

1 joint publications

Sven G Meuth

1 joint publications

Tobias Ruck

1 joint publications

Danielle H Bodicoat

1 joint publications

Maria de Francesco

1 joint publications

Sergio Iannazzo

1 joint publications

Jonathan D Santoro

1 joint publications

Jonathan Crowe

1 joint publications

Emily Klatte

Frequent Collaborators

1 joint publications

Cécile van Steen

1 joint publications

Tim Hagenacker

1 joint publications

Sven G Meuth

1 joint publications

Tobias Ruck

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on : May 07, 2020

7.3K
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on : Sep 14, 2019

8.5K
Adjuvant Activity of <em>Mycobacterium paratuberculosis</em> in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Adjuvant Activity of <em>Mycobacterium paratuberculosis</em> in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on : May 12, 2023

2.1K
See more related videos

Top Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on : May 07, 2020

7.3K
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on : Sep 14, 2019

8.5K
Adjuvant Activity of <em>Mycobacterium paratuberculosis</em> in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
06:57

Adjuvant Activity of <em>Mycobacterium paratuberculosis</em> in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

Published on : May 12, 2023

2.1K
See more related videos